Axes 1–2
Traceability and studiedness
Scored using the available matching evidence. Identity: A commercial strain code is printed. Quantity disclosure: 100.0%. Potency: Potency is stated at manufacture.
product · release 2026-09-20
1MD BalanceMD
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Organisms, fibers and substances on this label
Printed organisms · observed
Organism list
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lactobacillus acidophilus L61A | Lactobacillus acidophilus | L61A | not printed | 18,000,000,000 CFU | T3; observed; quantity printed |
Pack, dose and cost
What the label says beyond the organisms
- Pack
- 60 Capsule(s) · Capsule
- Serving
- 2 Capsule(s) · 1 serving(s) a day
- Days of supply
- 30
- Potency per day
- 18,000,000,000 CFU
- Cost per day
- no observed price in this release
- Printed claims
- 2 on the label (All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
- Other ingredients
- 3 printed: Vegetable Cellulose Capsule, Rice Flour, Silica
- Label target groups
- Adult (18 - 50 Years), Women (not pregnant or lactating), Dairy Free
- Suggested use
- Suggested Use: As a dietary supplement, adults take two (2) capsules one (1x) daily before a meal, or as recommended by a healthcare professional.
- UPC
- X002PTP5C3
Printed potency
Quantity on the label
18,000,000,000 CFU per serving across 1 of 1 printed organism rows; potency basis Potency is stated at manufacture.
Evidence behind the label
Located human trials per organism
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Arabinogalactan | 13 |
| Lactobacillus acidophilus | 381 |
| Lactobacillus acidophilus L61A | 0 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 5.5% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
| Other products carrying the same strain | Shared strain | Gut Index Score | Observed price |
|---|---|---|---|
| 1MD BiomeMD for Women | L61A | 43.03 | not observed |
| 1MD BiomeMD | L61A | 42.42 | not observed |
| 1MD Nutrition BiomeMD | L61A | 39.22 | not observed |
A174.50
A20.00
GIS33.52
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 0.00–37.72; rank uncertainty 2997.00–3264.00; rank class 4.
Versions
Typed label snapshot edges
- 246723 → 274791: snapshot comparison. No change in organisms, printed CFU or potency basis between these snapshots.
- 246723 → 274791: snapshot comparison. No change in organisms, printed CFU or potency basis between these snapshots.
- 246723 → 274791: snapshot comparison. No change in organisms, printed CFU or potency basis between these snapshots.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Brand: 1MD — every published product of this brand, its potency basis and its observed reformulations.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). 1MD BalanceMD. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/balancemd/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
1MD BalanceMD: 1 of 1 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 274791. Window: NIH DSLD snapshot Sep 2026.
1 / 1 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371MD BalanceMD: 2 of 2 observed label snapshots state a potency basis; latest basis is at manufacture. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
2 / 2 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371MD BalanceMD: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 33.52 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371MD BalanceMD has 2 observed versions across 2 formulation groups; last recorded edge type: available at the same time. Window: NIH DSLD snapshot Sep 2026.
2 / 2 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371MD BalanceMD: 0 of 2 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437